Physician profile
Cynthia B Dunham
NPI 1821038498
$140.47
in general payments reported to CMS, 2019-2025
7 companies · none reported in 2025
See the full distribution for Nephrology (Internal Medicine)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $67.84 · 2020: $52.94 · 2021: $19.69.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Akebia Therapeutics INC | $32.19 | 2019-2020 | |
| Mallinckrodt Hospital Products INC. | $23.95 | 2020 | |
| Vifor Pharma, INC. | $22.63 | 2019 | |
| Aurinia Pharma U.S., INC. | $19.69 | 2021 | |
| Amicus Therapeutics, INC. | $16.71 | 2019 | |
| Amgen INC. | $12.67 | 2019 | |
| Horizon Therapeutics Plc | $12.63 | 2020 |
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Cynthia Dunham listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.